The present disclosure relates to the field of sterilization or disinfection systems and methods.
Medical devices may include access sites for the administration of fluids, nutrients, medications, and blood products to patients. For example, central venous access using a catheter or central line is a common medical practice used in hospitals to deliver medication to a patient and perform various treatments and/or laboratory tests. As another example, dialysis catheters may be used for exchanging blood to and from a hemodialysis machine from the patient. Many hospitalized patients, particularly intensive care and perioperative patients, are provided with indwelling catheters for medication delivery and/or monitoring. In central venous access, for example, a central venous catheter is placed in a large vein, e.g., in the neck, shoulder, or groin, to permit repeated direct access via an external access site to the bloodstream of the patient. Such catheters bypass natural barriers, offer direct access to the circulation, and often remain in the patient's body for a week or more.
Such access sites may become contaminated during routine use when the access site is exposed to the environment, interfaces with delivery mechanisms, is manipulated by healthcare personnel, etc. Further, entry points of medical devices in a patient, e.g., an entry point of a catheter in the skin of a patient, may also become contaminated. Contamination of access sites and entry points may give rise to harmful infections which arise from microorganisms, such as bacteria, entering the body of a patient via the access sites. For example, if a port in a central venous catheter or a dialysis catheter inserted into a patient becomes contaminated, then an infection, such as central venous catheter-associated bloodstream infection (CLABSI), may occur when fluids are introduced into the bloodstream of the patient via the contaminated port. Catheter ports may be repeatedly used, e.g., accessed 10-30 times daily, and may remain in place for relatively long periods of time thereby increasing risk of infection from contaminated injection ports. Such infections may lead to increased morbidity and mortality, and increased health care costs. For example, post-operative infections may lead to longer hospital stays which are costly for both patients and health care providers. Because of this, it is desirable for hospital staff and physicians to keep access sites disinfected or sufficiently sterilized.
Approaches for sterilizing or disinfecting access sites in order to attempt to reduce infections include chemical disinfection, antibiotic port flushes, and antibiotic coatings. However, antibiotic flushes and coatings may increase the incidence of resistant infection and expose patients to the risk of allergic reactions, which are potentially lethal. In some approaches, after catheter placement, isopropyl alcohol swabs may be used to sanitize injection ports of the catheter prior to each use in a process called “scrubbing the hub.” However, such an approach may be inadequate or ineffective due to the effort and time it takes to sufficiently scrub the hub in order to achieve adequate sanitization. Since practitioners may access catheters or other access sites many times, such an intervention imposes hardship, reduces practitioner availability for other tasks, and is likely underperformed in emergencies.
The issues identified above are not necessarily admitted to be well known and are recognized by the inventors of the present application.
The present disclosure is directed to devices and methods for maintaining disinfection of access sites of medical devices, such as ports of catheters or other medical tubing, using an ultraviolet (UV) light source which is selectively illuminated during various conditions in order keep the access sites sterile and ready for use. UV light sterilizes materials by using a wavelength of light that breaks the molecular bonds in microbe DNA which either destroys them, rendering them harmless, or prohibits their growth and reproduction thus taking away their ability to cause infection.
In one example approach, a device may comprise a power supply, e.g., one or more batteries, and a UV light source, e.g., one or more UV light-emitting diodes, incorporated into a chamber of an enclosure which is closeable over one or more access ports to cover or enclose the access ports within the chamber. For example, such an enclosure may include a sealing member, e.g., a door, which is adjustable between an open position where the access sites are exposed and a closed position where the access sites are enclosed within the chamber.
The device may also include a controller, e.g., a microprocessor or other suitable computing device, which actuates the UV light source within the chamber to illuminate the UV light source based on various conditions. For example, in response to an adjustment of the enclosure from the open position to the closed position wherein the access sites are enclosed within the chamber of the enclosure, the ultraviolet light source may be illuminated for a predetermined first duration while the enclosure is maintained in the closed position. Following illumination of the ultraviolet light source for the first duration, the ultraviolet light source may then be illuminated for a predetermined second duration at predetermined time intervals while the enclosure is maintained in the closed position. In this way, following an initial disinfection with UV light, disinfection of the access sites may be maintained by periodically cycling UV light treatment of the access sites while the access sites remain enclosed within the chamber.
In some examples, a notification system may be included with the device. The notification system may provide indications of various operating conditions of the device. For example, the notification system may provide visual signals indicating when the UV light is illuminated and/or indicating a disinfection state of the access ports enclosed within the chamber of the enclosure. For example, the notification system may include an alarm and/or locking mechanism to warn a user that the device has been opened while the access sites are not in “non-infectious status,” e.g., before a full UV dose has been delivered to adequately disinfect or sterilize the access sites.
In some examples, the durations and/or intensities of the UV light used to disinfect the access sites enclosed within the chamber may be adjusted based on various physical attributes of the device (e.g., the geometry of the chamber within which the access sites are contained), the type of access sites being sanitized, and/or based on a calibration of the device for a particular application in a given therapeutic setting. For example, the durations and/or intensities of the UV light may be adjusted based on data obtained from a look-up table. The data in the look-up table may be obtained from models based on experimental data which correlates UV dosing parameters with physical attributes of the device and the type of access sites included in the device. Additionally, microbiologic data which describes microbe-specific dosing and timing of UV light may be used to adjust the durations and/or intensities of the UV light to ensure adequate sanitization while using a minimal amount of UV light. In this way, non-infectiousness of access sites may be guaranteed whenever the access sites are accessed while potentially reducing power consumption of the device.
In some examples, some components of the device may be packaged in a modular fashion. For example, the device may comprise a precisely defined, two part body or housing which constrains the geometry of the access sites or ports (of potentially many different port-containing devices). For example, a transmitting portion or module may contain a controller, a UV source, a battery, and may be reusable and interchangeable with different receiving portions or modules which incorporate, house, or otherwise attached to ports of intravenous or other medical devices with access sites of potential infection risk. In this example, the controller in the transmitting module may be used to illuminate the UV light source using a minimal amount of energy sufficient to adequately disinfect access ports in a particular receiving module to which the transmitting module is coupled. In this way, power consumption of the device may be reduced, e.g., battery life may be extended, and dimensional constraints of the device may be reduced so that the device may be used in a portable fashion, for example.
Such an approach enables automated disinfection of access sites by ensuring that the access sites are clean of microbial contamination before each use. Automatically maintaining access site disinfection in this way may lead to a reduction or prevention of infections during surgeries and procedures involving medical devices with access sites which are prone to contamination. Because such an approach is automated, practitioner hardships and errors associated with repeatedly performing arduous tasks every time a port is accessed may be reduced thereby potentially freeing up practitioner availability for other tasks while reducing healthcare costs associated with infection occurrences in patients.
This Summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used to limit the scope of the claimed subject matter. Furthermore, the claimed subject matter is not limited to implementations that solve any or all disadvantages noted in any part of this disclosure.
Embodiments described herein are directed to devices and methods for automatically maintaining disinfection of access sites of medical devices, such as ports/hubs of central venous catheters, dialysis catheters, or other medical tubing, using an ultraviolet (UV) light source which is selectively illuminated during various conditions in order keep the access sites sterile and ready for use. As used herein, the term “access site” may refer to any element of a medical device which is potentially exposed to contamination, e.g., injection ports of catheters or skin entry points of catheters in a patient. Further, the terms “access site,” “port,” “hub,” and “entry point” as used herein are synonymous.
The term “disinfected” as used herein refers to bacterial colony counts being reduced below a threshold level. For example, as used herein, an access site which is disinfected may refer to an access site which has had 50%, 60%, 80%, 90%, or 99% of the bacteria on the access site destroyed or removed. Further, the term “non-disinfected state” as used herein may refer to bacterial colony counts remaining greater than a threshold level. Further, indicating a non-disinfection state as used herein may refer to indicating an amount or percentage of bacteria on the access site which has been destroyed or removed. The term “sufficiently disinfected” when used in reference to an access site may refer to an access site which has had at least a predetermined threshold amount of bacteria on the access site destroyed. In some examples, the term “sterilized” as used herein may refer an access site which has had substantially all of the bacteria on the access site destroyed or removed.
Turning to the figures,
Device 100 comprises a plurality of different components which may be included within a single body or housing. In some examples, some components of the device may be packaged or grouped together in a modular fashion. For example, the device may comprise a precisely defined, two part box which constrains the geometry of the access sites or ports (of potentially many different port-containing devices). For example, a transmitting portion or transmitting module 104 may contain a controller 120, a UV source 118, a power source 122 such as a battery, and other components (examples of which are described below). The transmitting module 104 may be self-contained, reusable, and interchangeable with different receiving portions or receiving modules which incorporate, house, or otherwise attached to ports of intravenous or other medical devices with access ports of potential infection risk. In this example, the controller 120 in the transmitting module 104 may be used to illuminate the UV light source 118 using a minimal amount of energy sufficient to adequately disinfect access ports in a particular receiving module to which the transmitting module is coupled.
In some examples, the transmitting module 104 and the receiving module 102 may include complementary mating features 128 so that the transmitting module may be releasably coupled to the receiving module such that the ultraviolet light source in the transmitting module is configured to direct ultraviolet light into a chamber 108 of an enclosure 107 of the receiving module 102. For example, different receiving modules with different geometries (e.g., physical dimensions and shapes) may include docking elements for receiving the transmitting module 104. For example, the transmitting module 104 may be removed from a first receiving module and installed in a second, different receiving module.
In order to calibrate operational features of the transmitting module to perform optimally for a specific configuration of a receiving module to which it is attached or within which it is installed, a detecting device 131 may be included in the transmitting module 104 for detecting the receiving portion. For example, the detecting device 131 may include one or more sensors configured to detect geometric dimensions of the chamber of the receiving module so that various operational features, such as UV light dose durations and UV light intensities, may be adjusted. In this way, the detection device may be used to recognize and identify the receiving module in order to determine the type and number of access sites contained in the receiving module and which UV light algorithm/regimen should be used during disinfection maintenance. For example, a central line may most likely be infected by staphylococcus aureus (staph), thus a staph killing UV dose and timing may be used. As another example, if the device is attached to a urinary catheter, the contaminating organism may be escherichia coli (e. coli), therefore a different UV dose and timing may be used. In some examples, user input may be used to calibrate operational features of the transmitting module after it is installed into a receiving module. For example, a user may input a receiving module type, size, volume, shape or other physical parameters associated with the receiving module into a user interface included in the transmitting module so that operating parameters of the transmitting module can be tailored to the specific receiving module to which it is attached.
The receiving module 102 comprises an enclosure 107 configured to engage an end 114 of a medical device 112 such that an access site 116 of the medical device 112 is positioned within a chamber 108 of the enclosure. The chamber 108 may be defined by enclosure walls 106 which form a reservoir around installed access ports. The chamber may have any suitable geometry, e.g., any suitable length, width, depth, and shape (examples of which are described herein). For example, the enclosure walls 106 may include two pairs of opposing side walls extending upwardly from a bottom surface to form an enclave within the enclosure walls.
The enclosure may include a sealing member 181, e.g., a door, flap, or other moveable member, which is coupled to device 100 via a moveable coupling element 183, e.g., one or more hinges or similar features, so that the sealing member is adjustable between a first and second position. For example, in the first position the sealing member may expose the interior of chamber 108 and any access ports contained therein, and in the second position the sealing member may cover the chamber 108 so that any access ports in the chamber are enclosed within the chamber and cannot be accessed unless the sealing member is opened. By adjusting the sealing member to the second position, the enclosure is placed in a closed position. In the closed position, the enclosure 107 is configured to enclose the access sites, e.g., access site 116, within the chamber 108. By adjusting the sealing member to the first position, the enclosure is placed in an open position. In the open position the enclosure is configured to expose the access sites, e.g., access site 116. In the closed position, a complete and uninterrupted light-tight seal may be formed preventing light from escaping out of the enclosure.
For example, the enclosure 107 may be closed around the injection hubs of a multi-lumen central venous catheter or the entry points or a dialysis catheter. When closed, the enclosure does not occlude or compress the catheter lumens but encloses the injection hubs completely within chamber 108. The enclosure may fit over an IV port or central line ports and may be configured to accept injection hubs and hold the hubs in a position within chamber 108 which is in a path of maximal light from the UV light source 118. As described in more detail below, when the enclosure is closed around the access sites, the UV light source may be illuminated to kill or disable bacteria on the access sites with UV light. After a predetermined time duration has elapsed, where the predetermined time duration may depend on a strength (e.g., a wavelength and/or intensity) of the UV light source, the UV light source may be turned off. In some embodiments, to keep bacterial counts low, the UV light may be cycled on again periodically if the enclosure is not opened.
In some examples, the enclosure walls surrounding the chamber may be composed of an opaque or semi-opaque material, e.g., a plastic or other suitable UV light shielding material so that when the UV light source is illuminated while the enclosure is in the closed position, substantially no UV light will exit the chamber during the disinfection process. Further, in some examples, a least a portion of the interior walls of the enclosure, e.g., the interior walls defining chamber 108, may include a UV-reflective coating, e.g., a mirror coating, in order to increase an amount of UV light directed to the access sites.
As remarked above, the transmitting module 104 includes an ultraviolet light source 118. When the transmitting module 104 is installed within, coupled to, or mated with a receiving module, the UV light source is positioned to specifically direct light onto the access sites within the chamber and may not transmit light onto portions of the medical device outside of the chamber. For example, UV light may be constrained by the device so that UV light is not transmitted through the tube lumen interior of a catheter beyond the access site of the catheter.
The UV light source 118 may comprise one or more of any suitable UV light sources. For example, the UV light source may comprise one or more ultraviolet light-emitting diodes (LEDs). Other nonlimiting example UV light sources include mercury lamps, black lights, short wave ultraviolet lamps, ultraviolet lasers, gas discharge lamps, etc. The frequency/wavelength of light emitted from the UV light source may be any suitable frequency/wavelength within the UV range such as wavelengths in a range between 400 nm and 10 nm, e.g., a wavelength of 260 nm may be used. In some examples, the frequency/wavelength and/or intensity of the UV light may be adjusted based on a geometry of the chamber 108, the types of access sites included in the chamber, a state of charge of a battery included in the device, etc. Further, the number of UV sources used and the types of UV sources actuated in the device may depend on a particular application or a specific geometry of the receiver portion in which the transmitting portion is included. In some embodiments, the wavelength of the UV light may be selected based on an identified optimal germicidal effectiveness and/or absorbances of germicidal moieties such as cytosine, adenine, guanine, thymine, uracil, etc. For example, a low pressure UV light may be configured to emit UV light having a wavelength in an approximate range of 240-260 nm, e.g., 253.7 nm, and a medium pressure UV light may be configured to emit UV light having a wavelength in an approximate range of 300-320 nm.
The power source 122 included in the transmitting module 104 may comprise any suitable power supply. For example, the power source may comprise one or more batteries, e.g., rechargeable batteries such as lead-acid, nickel cadmium (NiCd), nickel metal hydride (NiMH), lithium ion (Li-ion), or lithium ion polymer (Li-ion polymer) batteries. As another example, power source 122 may be coupled to an external power supply such as an external outlet, generator, or battery. In some embodiments, one or more Universal Serial Bus (USB) ports may be included in the device so that, when attached to a USB port in the device, a USB cord may supply power to the device, e.g., to recharge one or more batteries in the device. As another example, when attached to a USB port in the device, a USB cord may be used to transmit data to and/or from an external computing device or system.
In some examples, the transmitting module 104 may include a switch 125 in communication with controller 120. The switch may be actuated when the enclosure 107 is adjusted from the closed position to the open position or from the open position to the closed position. For example, switch 125 may interface with sealing member 181 and may be configured to be actuated in response to a change in position of the sealing member between the first position and the second position to determine if the device is opened or closed. As another example, switch 125 may comprise an actuating mechanism that may be actuated by a user of the device to initiate UV disinfection and/or disable UV disinfection of any access sites included in the device.
In some examples, device 100 may include a locking mechanism 126. The locking mechanism 126 may interface with sealing member 181 to lock the sealing member in a closed position during certain conditions. For example, the locking mechanism may comprise a latch which is configured to engage with a portion of the sealing member in response to a signal received from controller 120. For example, the locking mechanism 126 may be configured to prevent adjustment of the enclosure from the closed position to the open position and the controller may be configured to lock the enclosure in the closed position via the locking mechanism when the ultraviolet light source is illuminated and/or when the access sites in the chamber are in a non-disinfected state. By preventing access to the chamber during certain conditions, e.g., if the UV light is powered on and/or if the access sites are in a non-disinfected state, the locking mechanism may prevent user exposure to UV light and prevent use of a contaminated access site until a disinfection cycle is complete.
In some examples, the transmitting portion may further include a locking override mechanism 127 which may be used to override or disengage the locking mechanism 126 during certain conditions. For example, in response to an actuation of the locking override mechanism while the enclosure is in the closed position and the ultraviolet light source is illuminated, illumination of the ultraviolet light source may be discontinued and the locking mechanism may be unlocked to permit adjustment of the enclosure from the closed position to the open position. The locking mechanism may comprise a manually actuated button or switch, a speech input device, or other suitable user input device which may be actuated by a user to bypass the locking mechanism in order to open the device, e.g., in cases of emergency.
In some examples, the transmitting portion may further include a notification system 124. Notification system 124 may include one or more indicator elements such as display devices, lights (e.g., LED lights), audio speakers, haptic devices, etc. For example, notification system 124 may be used to indicate various operational states of the device, e.g., whether the UV light is on or off, whether the enclosure is in the open or closed state, whether the access ports are sufficiently disinfected or not, etc. For example, the notification system may include a light which may be illuminated in response to certain conditions, or a color of the light may be changed to indicate a change in the operational state of the device, or speakers in the notification system may emit sounds or vibrations in response to a change in operational state. As an example, the notification system may be used to provide an alarm to warn a user that the device has been opened while ports are not in “non-infectious status,” e.g., before a full UV dose has been delivered to achieve sufficient disinfection. As another example, an indication may be provided to the user by the notification system via a visual signal when an access port in the chamber of the enclosure may be safely used because a disinfection cycle is complete.
In some examples, usage data of device 100 may be recorded and/or broadcast to an external computing device. Thus, the transmitting module 104 may include a broadcasting device 130 which is configured to send device usage data to a remote computing device over a network. Nonlimiting examples of broadcast devices include antennas, modems, radio transmitters, ethernet ports, USB ports, etc. For example, for each adjustment of the enclosure from the closed position to the open position, an access timestamp may be associated with said adjustment and stored in a data-holding system in the transmitting module and, if said adjustment is performed while the access sites are in a non-disinfected state, a flag may be associated with the access timestamp and stored in the data-holding subsystem. This usage data (the access time-stamps and flags) may then be sent to a remote computing device via the broadcasting device 130. In this way, usage data may be used to generate reports for medical personnel or supervisors for compliance evaluations or other applications. For example, the usage data may include information relating to how often a port was accessed during a given time period and if and how often a port was accessed while the port was in a non-disinfected or potentially contaminated state.
The controller 120 may comprise any suitable computing device. In some embodiments, the controller may comprise physical circuitry, e.g., physical circuitry on a printed circuit board (PCB), programmed to perform one or more of the various acts described herein. For example, controller 120 may comprise a small microprocessor with a timing circuit which controls the on-off cycling of the UV source such that every time the device is closed the UV light is switched on for a first duration and then periodically switched on in order to maintain disinfection of the access sites. The UV light on/off cycling may be timed to ensure that the ports are sterile whenever they are accessed. For example, the enclosure may be placed on the ports of a catheter at the time of catheter line placement in a patient and opened whenever it is necessary to access the line. Following access, the enclosure may be re-closed and the ultraviolet light cycling resumed. While the enclosure is open, the light may be prevented from illuminating, thus shielding the patient and provider. The controller may include a logic subsystem and a data-holding subsystem comprising machine-readable instructions stored thereon that are executable by the logic subsystem to perform various disinfection maintenance methods, such as the example method 1000 described below. The routines and instructions described herein may represent code stored in the controller and may be carried out by the controller in cooperation with one or more hardware elements, including sensors, actuators, etc. In this way, example methods described herein may be carried out by the controller operating in combination with one or more hardware elements, such as the noted sensors, actuators, etc.
The transmitting module 104 is included within the body or housing of the receiving module 102 such that the UV light from the UV light source 118 is directed into the chamber 108. A door 181 is coupled to a top portion of wall 208 via hinges 216 to permit the adjustment of the door between a first position placing the enclosure in the open position as shown in
The access site may be held within the chamber 108 of the device in any suitable way. As another example,
As remarked above, in some examples, some components of the device may be packaged or grouped together in a modular fashion. For example, the transmitting module 104 may be self-contained, reusable, and interchangeable with different receiving modules which incorporate, house, or otherwise attached to ports of intravenous or other medical devices with access ports of potential infection risk. For example,
In order to calibrate operational features of the transmitting module 104 to accommodate the different configurations of the different receiving modules 704 and 708, a calibration may be performed in the transmitting module 104 in order to adjust an intensity of the UV light emitted from the light source and/or a duration of illumination of the UV light source to achieve adequate disinfection of the ports. For example, since distance 702 in chamber 708 of device 700 is greater than distance 802 in chamber 808 of device 800, an intensity and/or duration of UV illumination used in device 700 may be greater than an intensity and/or duration of UV illumination used in device 800.
Further, an intensity and/or duration of UV illumination used by the transmitting module may also depend on the type of access ports enclosed in the receiving module. In some examples, the type of access ports enclosed in the receiving module may be determined based on an identification of the receiving module, e.g., via a detection device or user input as described above. The calibration of operating parameters of the transmitting module may be based on data obtained from a lookup table, e.g., a lookup table stored in a memory component in the device. For example, given a specific geometry, configuration, or application of a particular receiving module, corresponding UV dosing information contained in a lookup table may be loaded into the controller to control the UV light source. The data in the lookup table may be based on models obtained from results of experiments which correlate UV dosing parameters with a given UV light source for particular access ports in particular receiving module configurations in order to obtain adequate disinfection.
At 1102, method 1100 may include detecting a configuration of the device. For example, detecting device 131 may be used to detect geometric dimensions of a chamber of a receiving module within which a transmitting module is installed so that various operational features, e.g., UV light dose durations, UV light maintenance scheduling, and/or UV light intensities, may be adjusted. As remarked above, the detection device may be used to recognize and identify the receiving module and, therefore what kind of port and which UV light algorithm/regimen should be used during disinfection maintenance. In some examples, user input may be provided to the device via a suitable user input device. For example, a user may input a receiving module type, size, volume, shape or other physical parameters associated with the receiving module into a user interface included in the transmitting module so that operating parameters of the transmitting module can be tailored to the specific receiving module to which it is attached.
At 1104, method 1100 may include calibrating the device. For example, based on the detected configuration of the device, e.g., the detected geometric dimensions of a chamber in an enclosure of the receiving module, operational parameters of the transmitting module may be calibrated. As remarked above, the calibration of operating parameters of the transmitting module may be based on data obtained from a lookup table stored in a memory component in the device. For example, given a specific geometry, configuration, or application of a particular receiving module, corresponding UV dosing information such as UV intensity, UV duration, and UV illumination scheduling may be loaded into the controller to control the UV light source. The data in the lookup table may be based on models obtained from results of experiments which correlate UV dosing parameters with a given UV light source for particular access ports in particular receiving module configurations in order to obtain adequate disinfection. Examples of UV dosing information which may be calibrated include a first duration of UV light illumination which is used after an initial closure of the device around access sites and a second time duration of UV illumination which is used to periodically maintain disinfection of the access sites while the device remains closed around the access sites. In some examples, this second duration of illumination used to maintain disinfection may be shorter than the first duration used to perform an initial disinfection following closure of the device around the access ports.
At 1106, method 1100 includes determining if a transition from an open position to a closed position is detected. For example, switch 125 may be used to monitor adjustments of sealing member 181 from the open position to the closed position to determine when the device is closed around access ports. If a transition from the open position to the closed position is not detected at 1106, method 1100 may end or may return to continue monitoring the device to detect changes from the open to closed state or to detect other configuration changes of the device. However, if a transition from an open position to a closed position is detected at 1106, method 1100 proceeds to 1108.
At 1108, method 1100 includes illuminating the UV source. For example, the controller 120 may send a signal to the UV light source to cause the UV light source to become illuminated for a predetermined first duration while the enclosure is maintained in the closed position. The predetermined first duration may be obtained from a look-up table and may be based on configuration information associated with the device or access sites contained within the device. In this way, after the device is closed around access sites an initial UV dose may be applied to the access ports for the first duration in order to sufficiently sanitize the access sites.
At 1110, method 1100 may include locking the device. For example, the controller 120 may send a signal to locking mechanism 126 to cause the locking mechanism to engage with the sealing member 181 so as to lock the enclosure in the closed position while the ultraviolet light source is illuminated. In this way, the locking mechanism 126 may prevent adjustment of the enclosure from the closed position to the open position while the ultraviolet light source is illuminated to sanitize the access sites.
At 1112, method 1100 may include providing an indication that the UV light is on. For example, controller 120 may send a signal to the notification system 124 to actuate one or more indicators in the notification system to provide an indication that the ultraviolet light is illuminated. At 1114, method 1100 may include providing an indication that the access sites within the device is in a non-disinfected state. For example, controller 120 may send a signal to the notification system 124 to actuate one or more indicators in the notification system to provide an indication that the first duration has not yet elapsed and thus the access sites may not yet be in a sufficiently disinfected or sterilized state. As remarked above, the notification system may include various indicators such as lights, speakers, haptic devices, etc. which may be actuated by the controller to provide visual, audible, and/or haptic indications of operational states of the device.
At 1116, method 1100 includes determining if the first duration has elapsed. For example, the controller 120 may include a timing circuit which determines when/if the first duration of UV illumination has elapsed following the initial closure of the device around the access sites. If the first duration has not elapsed at 1116, method 1100 proceeds to 1118 to determine if a transition from the closed position to the open position is detected. For example, switch 125 may be used to monitor adjustments of sealing member 181 from the closed position to the open position to determine if an adjustment of the device from the closed position to the open position is initiated. In some examples, while the UV light is illuminated the device may be maintained locked, e.g., via locking mechanism 126, in order to prevent access to the access sites before the access sites are sufficiently disinfected or to prevent user exposure to UV light. Thus, in some examples, determining if a transition from the closed position to the open position is detected may include determining if a locking override mechanism is actuated. For example, a user may provide input to actuate the locking override mechanism 127 in order to bypass the locking mechanism so that the device may be opened. As described below, in response to an actuation of the locking override mechanism while the enclosure is in the closed position and the of a medical device such that an access site of the medical device is positioned within a chamber tinued and the locking mechanism may be unlocked to permit adjustment of the enclosure from the closed position to the open position.
If a transition from the closed position to the open position is not detected at 1118, method 1100 proceeds back to 1108 to continue illuminating the UV source for the first duration to disinfect the access sites. However, if a transition from the closed position to the open position is detected at 1118, then method 1100 proceeds to 1120. At 1120, method 1100 includes discontinuing UV illumination. For example, the controller may be configured to discontinue illumination of the ultraviolet light source in response to an adjustment of the enclosure from the closed position to the open position so that exposure of a user to UV light is prevented when the device is opened.
At 1122, method 1100 may include providing an indication that the UV light is off. For example, controller 120 may send a signal to the notification system 124 to actuate one or more indicators in the notification system to provide an indication that the ultraviolet light is not illuminated. At 1124, method 1100 may include providing an indication that the access sites within the device are in a non-disinfected state since the UV disinfection dose was terminated before adequate disinfection or maintenance of disinfection is complete.
At 1126, method 1100 may include recording and/or reporting device usage data. As remarked above, in some examples, usage data of device 100 may be recorded and/or broadcast to an external computing device. Thus, the transmitting module 104 may include a broadcasting device 130 which is configured to send device usage data to a remote computing device over a network. For example, for each adjustment of the enclosure from the closed position to the open position, an access timestamp may be associated with said adjustment and stored in a data-holding system in the transmitting module and, if said adjustment is performed while the access sites are in a non-disinfected state, a flag may be associated with the access timestamp and stored in the data-holding subsystem. This usage data (the access time-stamps and flags) may then be sent to a remote computing device via the broadcasting device 130.
At 1128, method 1100 may include unlocking the device. For example, the controller 120 may send a signal to locking mechanism 126 to cause the locking mechanism to disengage with the sealing member 181, e.g., by deactuating the locking mechanism, so as to unlock the enclosure after illumination of the ultraviolet light source is terminated so that the device may be opened and the access sites accessed by a user.
Returning to 1116, if the first duration of UV illumination used to initially disinfect the access ports following closure of the access sites within the device has elapsed, then method 1100 proceeds to 1130. At 1130, method 1100 includes discontinuing UV illumination, and, at 1132, method 1100 may include providing an indication, e.g., via the notification system 124, that the UV light is off. At 1134, method 1100 may include providing an indication, e.g., via the notification system 124, that the access sites within the device are in a sufficiently disinfected state. At 1136, method 1100 may include recording and/or reporting usage data, and, at 1138, method 1100 may include unlocking the device so that device may be opened by a user to access the disinfected access ports.
At 1140, method 1100 includes determining if a transition from the closed position to the open position is detected. For example, a user may open the unlocked device in order to access the access ports to administer fluids or perform other operations using the disinfected access sites. If a transition from the closed position to the open position is detected at 1140, then method 1100 may end or return to start. However, if a transition from the closed position to the open position is not detected at 1140, e.g., if the device remains in the closed position following the initial UV disinfection for the first duration, then UV light may be used to maintain disinfection of the access sites while the device remains closed around the access sites and thus method 1100 proceeds to 1142.
At 1142, method 1100 includes determining if a predetermined time interval has elapsed. For example, after the initial disinfection of the access sites for the first duration, the UV light source may be illuminated at predetermined time intervals while the device remains closed around the access ports in order to maintain sufficient disinfection of the access ports. The predetermined time interval may be based on configuration information of the device detected in step 1102 described above and may be adjusted based on this configuration information. For example, if the transmitting module is coupled with a first receiving module, a first predetermined time interval may be used to schedule UV disinfection maintenance, whereas if the transmitting module is coupled with a second receiving module, a second, different predetermined time interval may be used to schedule UV disinfection maintenance.
If the predetermined time interval has not elapsed at 1142, then method 1100 proceeds back to 1140 to continue monitoring the device to detect a transition from the closed position to the open position while waiting until the predetermined time interval has elapsed. If the predetermined time interval has elapsed at 1142, then method 1100 proceeds to 1144.
At 1144, method 1100 includes illuminating the UV source. For example, the controller 120 may send a signal to the UV light source to cause the UV light source to become illuminated for a predetermined second duration while the enclosure is maintained in the closed position. The predetermined second duration may be obtained from a look-up table and may be based on configuration information associated with the device or access sites contained within the device. In this way, following illumination of the ultraviolet light source for the first duration, the ultraviolet light source may be illuminated for the predetermined second duration at predetermined time intervals while the enclosure is maintained in the closed position in order to maintain disinfection of the access sites. In some examples, the second duration may be shorter than the first duration since less UV illumination may be needed to perform the disinfection maintenance phase of the access sites.
At 1146, method 1100 may include locking the device. For example, the controller 120 may send a signal to locking mechanism 126 to cause the locking mechanism to engage with the sealing member 181 so as to lock the enclosure in the closed position while the ultraviolet light source is illuminated. At 1148, method 1100 may include providing an indication that the UV light is on. For example, controller 120 may send a signal to the notification system 124 to actuate one or more indicators in the notification system to provide an indication that the ultraviolet light is illuminated. At 1150, method 1100 may include providing an indication that the access sites within the device are in a non-disinfected state. For example, controller 120 may send a signal to the notification system 124 to actuate one or more indicators in the notification system to provide an indication that the second duration has not yet elapsed and thus the access sites may not yet be in a sufficiently disinfected state.
At 1152, method 1100 includes determining if the second duration has elapsed. For example, the controller 120 may include a timing circuit which determines when/if the second duration of UV illumination has elapsed. If the second duration has elapsed at 1152, then method 1100 proceeds back to 1130 to discontinue the UV light illumination, indicate that the UV light is off, indicate that the access sites are disinfected, and unlock the device so that the disinfected access ports may be accessed by a user.
However, if the second duration has not elapsed at 1152, then method 1100 proceeds to 1154. At 1154, method 1100 includes determining if a transition from the closed position to the open position is detected. If a transition from the closed position to the open position is detected at 1154, then method 1100 proceeds back to 1144 to continue illumination of the UV source to maintain disinfection of the access sites. However, if a transition from the closed position to the open position is detected at 1154 before the second duration has elapsed, then method 1100 proceeds to 1120 described above.
Before time t1 in
At time t2, the enclosure is closed around the access ports, e.g., following use of the access ports by a user. In order to disinfect the access ports in the enclosure, the UV light source is illuminated for a predetermined first duration from time t2 to t3 in order to adequately disinfect the access sites within the enclosure. During this time period from time t2 to t3, the device is maintained locked in order to prevent a user from opening the device while disinfection is being performed and the notification system provides an indication that the access sites are in a non-disinfected state.
At time t3, the first time duration has elapsed and the access sites are sufficiently disinfected, thus the device is unlocked and the notification system provides an indication that the access sites are sufficiently disinfected for use. After a predetermined time interval from time t3 to time t4, the UV light is again illuminated but for a shorter second time duration from t4 to t5 in order to maintain disinfection of the access sites in the enclosure. During this second duration from t4 to t5, the device is locked and the notification system indicates that the access ports are in a non-disinfected state. After the maintenance disinfection, at time t5 illumination of the UV source is discontinued, the device is unlocked, and the notification system provides an indication that the access ports are disinfected.
In order to continue maintaining disinfection of the access ports, the UV light is cycled on and off periodically. For example, following a time duration after t5, the UV light source is again illuminated for the second duration from time t6 to t7 during which time the device is locked and the notification system indicates that the access sites are non-sterilized or not sufficiently disinfected. After completion of the maintenance disinfection, at time t7 the illumination of the UV source is discontinued, the device is unlocked, and the notification system provides an indication that the access sites are sufficiently disinfected or sterilized.
At time t8, the enclosure is again opened. Since the enclosure is opened at time t8, the UV light source is maintained off, the device is unlocked, and the notification system is updated to indicate that the access sites are in a non-disinfected state. At time t9 the enclosure is closed around the access ports and the UV light source is illuminated to disinfect the access sites within the enclosure. However, at time t10 the device is opened prematurely, before a sufficient time duration of UV illumination has elapsed to sufficiently disinfect the access sites. For example, a user may press an override button to access the access sites in an emergency before disinfection is complete. Thus, at time t10 the UV illumination is terminated, the device is unlocked, and the notification system provides a warning that the access ports are in a non-disinfected state. The enclosure is then closed again at time t11 at which time the UV light source is illuminated for the predetermined first duration from time t11 to t12 in order to adequately disinfect of disinfect the access sites within the enclosure. During this time period, the device is maintained locked and the notification system provides an indication that the access ports are in a non-disinfected state.
At time t12, the first time duration has elapsed and the access sites are sufficiently disinfected, thus the device is unlocked and the notification system provides an indication that the access sites are sufficiently disinfected for use. After a predetermined time interval from time t12 to time t13, the UV light is again illuminated but for the shorter second time duration from t13 to t14 in order to maintain disinfection of the access sites in the enclosure. During this second duration from t13 to t14, the device is locked and the notification system indicates that the access ports are in a non-disinfected state. After the maintenance disinfection, at time t14 the illumination of the UV source is discontinued, the device is unlocked, and the notification system provides an indication that the access ports are sufficiently disinfected or sterilized.
In order to continue maintaining disinfection while the device remains closed around the access ports, following a time duration after t14 the UV light source is again illuminated at time t15. However, at time t16 the device is again opened prematurely before a sufficient time duration of UV illumination has elapsed to sufficiently maintain disinfection of the access ports. For example, a user may press an override button to access the access sites in an emergency before disinfection maintenance is complete. Thus, at time t16 the UV illumination is terminated, the device is unlocked, and the notification system provides a warning that the access ports are in a non-disinfected state.
Embodiment 1300 comprises a top cap 1302 coupled to a top portion or top surface of a bottom housing 1304. Top cap 1302 may include features that assist a user in grasping and turning the top cap. For example, top cap 1302 may be shaped like a “gas cap” (e.g., as used to seal a gas tank in an automobile) wherein two opposing sides of the cap taper inwardly in a direction towards the top of the cap to form two opposing indentations in the opposing sides of the cap. The tapered sides of the top cap may terminate at a handle element 1406 having a flat rectangular top surface. However, it should be understood that top cap 1302 may take any suitable shape. For example, top cap 1302 may be cylindrical or box-shaped and may include various other features that assist a user in grasping and rotating the cap.
A bottom portion 1420 of top cap 1302 includes features that are configured to mate with a top portion 1421 of bottom housing 1304. For example, a bottom portion of cap 1302 may include exterior threads configured to mate with interior threads on inner walls within an aperture 1408 in a top portion of bottom housing 1304 so that cap 1302 may be screwed or twisted into the aperture 1408 in housing 1304. As another example, cap 1302 may be coupled with a top portion of housing 1304 via a ratchet mechanism that allows a rotary motion of the cap relative to the housing in only one direction while substantially preventing rotary motion of the cap relative to the housing in the opposite direction. For example, a bottom portion of cap 1302 may include a gear mechanism configured to interface with pawl elements or vertical grooves in the interior walls of a top portion of housing 1304 in aperture 1408.
Aperture 1408 may be sized to hold and/or support various components of the device when the cap 1302 is coupled to the top portion of housing 1304. For example, as shown in
Embodiment 1300 additionally includes a tether 1306 having two opposing eyelets 1410 and 1412 coupled together by an elongated flexible attachment member 1429. For example, tether 1306 may comprise a cord coupled to two opposing rings or tether 1306 may comprise a piece of material with holes formed in each of the opposing ends. Tether 1306 may have any suitable shape and may be composed of any suitable flexible material including but not limited to rubber, flexible plastic, flexible polymer, leather, etc.
Tether 1306 is configured to couple embodiment 1300 of an injection port sterilizer to an end of an injection port or other medical device having an access port. In particular, eyelet 1410 has an internal diameter sized to accommodate a diameter of the components that couple cap 1302 with the top portion of housing 1304. For example, an outer diameter of eyelet 1410 may be slightly greater than the outer diameters of the bottom portion 1420 of cap 1302 and the top portion 1421 of housing 1304 and an inner diameter of eyelet 1410 may be slightly less than the outer diameters of the bottom portion 1420 of cap 1302 and the top portion 1421 of housing 1304. As illustrated at 1 in
A bottom portion 1480 of housing 1304 opposing cap 1302 may include an aperture 1392 having internal threads or other coupling members configured to mate with corresponding threads or coupling members on an end 114 of medical device 112. For example, as illustrated in
In operation, as illustrated at 2 in
As illustrated at 3 in
Ports may be snapped into the enclosure from beneath the enclosure so that the access sites 116 are held in a flat internal bottom surface 1514 within chamber 108. An opening 1506 is formed in the front side of enclosure 107 to provide increased access to the access sites 116 included in chamber 108 when the top flap 181 is in the open position. For example, as shown in
One or more UV light sources 118, e.g., UV fluorescent lamps, may be coupled to a bottom surface of top flap 181. In some embodiments, as shown in
The top flap 181 of embodiment 1500 comprises a top portion 1517 beneath which the UV light source(s) are coupled and a bent portion 1518 that forms an angle with the top portion. For example, the bent portion 1518 may form an angle of approximately 90 degrees relative to the top portion 1517 of the flap such that, when the top flap is moved to a closed position, the bent portion lies in a plane substantially parallel with the plane in which the front surface of the enclosure lies. When in the closed position, the bent portion of the top flap may overlap the opening 1506 in the enclosure.
The bent portion additionally includes slots, notches, or grooves 1504 formed therein. The grooves 1504 comprise openings extend a distance into the bent portion from a bottom edge 1520 of the bent portion. Lengths and widths of the grooves are sized to permit any lines or tubes connected to access ports mounted in the enclosure to exit the enclosure while the top flap is in the closed position. In some examples, the lateral positions of the grooves along the length of the bent portion of the top flap may substantially align with the access site locations on the internal bottom surface 1514 of the chamber such that there is a groove for each access site location in the enclosure. For example, if the device is configured to hold four access ports then there may be four grooves included in the bent portion of the top flap. However, any suitable number and positioning of grooves in the top flap may be used, e.g., there may be a greater or lesser number of grooves than access site locations.
Top flap 181 additionally includes a visual indicator 124, e.g., an LED light or other light source. In some examples, visual indicator 124 may be illuminated when the top flap is closed and when the UV light source(s) is illuminated. Illumination of the visual indicator 124 may be discontinued once the access ports are suitably disinfected while the top flap is in the closed position.
The chamber 108 formed by enclosure 107 may include one or more UV light sources for disinfecting access sites. In some examples, each access site location in enclosure 107 may have its own UV light source. In this example, when a flap positioned above an access site location in the enclosure is moved to the closed position, the device may be configured to illuminate the UV light source associated with that access site location and discontinue illumination of the UV light source when the flap is opened or when a sufficient period of time has elapsed to sufficiently disinfect an access site at the access site location. After disinfection of an access site, the corresponding flap may be opened so that the access site may be used, e.g., to connect a line 1666 to the access site.
Though not shown in
Embodiment 1700 comprises a coffin-shaped enclosure 107 have a first rounded end 1740 and a second smaller opposing rounded end 1742. As shown in
A coffin-shaped component 1808 comprising circuitry 1809 configured to implement the various disinfection routines described herein may be installed within base housing 1810. A circular aperture 1842 adjacent to end 1740 is formed in component 1808. A diameter of aperture 1842 may be sized to receive at least a portion of an end of medical device 1812. One or more UV light sources, e.g., LED UV lights, may be mounted on component 1808 adjacent to and around the internal edges of aperture 1842. In some examples, a plurality of UV light sources may be equally spaced around the circumference of aperture 1842. Any suitable number of UV light sources may be included on component 1808 in any suitable manner, e.g., 2, 4, or 6 equally spaced UV light sources may be mounted to component 1808 around aperture 1842. Component 1808 also includes a circular conductor 1842 mounted to a top surface of component 1808 adjacent to end 1742.
Enclosure 107 also includes a coffin-shaped top cap 1806 that is installed on top of component 1808 and coupled to the top edges of base housing 1810. Top cap 1806 includes a circular aperture 1844 at end 1740 that has a diameter larger than apertures 1842 and 1840. The diameter of aperture 1844 is sized to receive and hold a lens 1804. Lens 1804 may direct light from UV light sources 118 toward a flexible boot 1704 mounted on a top surface of top cap 1806. A smaller aperture 1845 is included in top cap 1806 adjacent to end 1742. Aperture 1845 has a diameter smaller than aperture 1844 and is sized to permit a terminal of a cylindrical battery (e.g., batteries 122) to be in physical contact with conductor 1843 in component 1808.
A battery cap 1850 is coupled to top cap 1806 above aperture 1845. Battery cap 1850 comprises a substantially hollow cylindrical body having a diameter sized to contain at least a portion of batteries 122 when the battery cap is rotatably coupled to top cap 1806. A conductor may be included in battery cap 1850 so that the top cap functions as a switch to actuate the device. For example, when cap 1850 is in a first position, the conductor may not provide an electrical connection between the top terminal of the top battery and component 1808, and when cap 1850 is rotated to a second position the conductor may provide an electrical connection between the top terminal of the top battery and component 1808. In this way, battery cap 1850 may function as an actuating mechanism (an on/off switch) such that when a user rotates the battery cap from a first position to a second position, the UV light source is illuminated to disinfect any access ports coupled within the device. Conversely, when a user applies a counter rotation to the battery cap, UV light illumination may be discontinued.
The flexible boot 1704 is coupled to top cap 1806 a locations adjacent the edges of aperture 1844 and over lens 1804. A bottom portion of boot 1704 may be coupled to top cap in any suitable manner, e.g., via an adhesive, an interference fit, mechanical coupling components, etc. Boot 1704 comprises a flexible material having a slit 1880 at a distal end 1890 of the boot opposing the top cap. The boot may be composed of any suitable flexible material, e.g., rubber, flexible plastic, leather, flexible polymer, ethylene vinyl acetate (EVA), etc. Boot 1704 may have front and back faces that taper inwardly towards each other to terminate at the elongated slit 1880. The slit 1880 may be substantially perpendicular to the tapering faces and the opposing ends of the elongated slit may terminate at two opposing sides 1884 and 1882 of the boot, where the two opposing sides 1884 and 1882 are substantially perpendicular to the tapered front and back faces of the boot. The slit 1880 is biased to remain in a closed position. A user may open slit 1880 by applying inward forces to the two opposing sides 1884 and 1882 of the boot. For example, a user may press opposing sides 1882 and 1884 towards each other to temporarily open the slit to insert an outlet port 1730 into the boot to be connected to an inlet port 1812 coupled to the device.
Receiving module 1910 comprises an enclosure 107 configured to hold a plurality of access sites (e.g., access site 116) of various medical devices (e.g., line 112). Enclosure 107 comprises two opposing side walls 2031 and 2033 and a flap 181 that is adjustable between an open position (as shown in
Enclosure 107 forms a chamber 108 within which ends of medical devices may be mounted for disinfection. In particular, enclosure 107 includes an internal platform 2050 adjacent to a bottom side of the enclosure and extending from a back wall of the enclosure towards a front side of the enclosure. Platform 2050 may include one or more notches or snap slots, e.g., slot 2051, sized to hold lines, tubes, or other components for attachment within chamber 108. For example, unused ports may be mounted within chamber 108 via the slots in platform 2050. Each slot in platform 2050 is positioned at a location along the platform to hold an access site directly in front of a corresponding elongated oval aperture in a back wall of the enclosure. For example, slot 2051 is configured to hold an access site directly in front of elongated oval aperture 2090.
A back wall of the enclosure 107 includes one or more elongated oval apertures positioned directly behind each access site location in the enclosure so that when the receiving module 1910 is coupled to the transmitting module 1908, UV light from UV light sources 118 included in the transmitting module 1908 is directed through the oval apertures towards the access site locations in chamber 108. The internal walls of the enclosure are concave around the perimeter of each elongated oval opening in the internal back surface of the enclosure to direct and spread UV light onto the associated access site locations. Additionally, the interior walls of the enclosure may be coated with a reflective material (e.g., chrome or the like) to increase UV light exposure to any access sites mounted in the enclosure.
An interlock tab 2030 is included at a location on an interior surface 2091 of flap 181 adjacent to a side edge 2093 of the flap. Tab 2030 is sized and shaped to fit through an aperture in the back wall of enclosure 107 and into a interlock port 2131 in a front wall of transmitting module 1908 such that when the flap 181 is closed while the receiving module is coupled to the transmitting module, the tab fits into port 2131 to activate the various disinfection routines described herein.
The front face 1931 of flap 181 may include a plurality of vertical slots 1906 (e.g., snap slots) extending substantially the entire height of the front face 1931. Vertical slots 1906 may be sized to receive and hold lines or tubes for mounting therein. For example, when a port 1902 is in use, the tube of the port may be mounted in one of the vertical slots on the front face of the enclosure as shown in
Flap 181 additionally includes tabs 1920 extending from a bottom edge 2096 of the flap to assist a user in opening the flap. Additionally, the bottom edge 2096 of the flap may include slots 2097 for stabilizing and positioning any tubes emanating from chamber 108 when flap 181 is in the closed position. In some examples, these slots 2097 may be positioned along the bottom edge 2096 between two tabs (e.g., tabs 1920) located adjacent to outer side edges of the flap.
In some examples, receiving module 1910 may be periodically replaced, and thus may be composed of relatively inexpensive materials, e.g., plastics and/or other consumable materials. For example, the receiving module 1910 may be removed from the transmitting module 1908 after a certain number of uses and replaced with a new receiving module.
Transmitting module 1908 may include sockets 2108 positioned adjacent to each corner of a front side of the transmitting module 1908. Sockets 2108 may be sized and shaped to receive corresponding mating components located on the back wall of the receiving module. In some examples, at least one socket may include a sensor configured to detect whether or not a receiving module is coupled to the transmitting module in order to prevent activation of UV light when there is no receiving module attached to the transmitting module.
The transmitting module includes a plurality of elongated oval-shaped UV light sources 118 that are positioned and embedded in a front face of the transmitting module at positions corresponding to the elongated oval apertures (e.g., aperture 2090) in the back wall of enclosure 107. When the receiving module is attached to the transmitting module, the UV light sources align with the apertures in the receiving module so that UV light can be directed onto each individual access site location within enclosure 107.
Transmitting module 1908 may include various notification systems or components, e.g., LED lights, timers, displays, etc. that indicate various operational states of the device. For example, one or more LEDs 1904 and/or a display 1940 may be included in a top surface of transmitting module 1908. For example, LEDs 1904 may be illuminated when the device is in operation (e.g., when the UV lights are illuminated) and/or display 1940 may display a timer indicating time information associated with operation of the device, e.g., how much time has elapsed following an initiation of UV light source illumination. Additionally, a clip 1604 may be included on the back surface of transmitting module 1908 as shown in
After the transmitting module 1908 is separated from the receiving module 1910, in some examples, the transmitting module 1908 may be releasably attached to a docking module 2202 as shown in
At 2303,
Embodiment 2400 comprises an outer shell 2406 within which a transmitting module 2408 may be housed. Outer shell 2406 comprises substantially parallel top and bottom surfaces, 2531 and 2533 respectively, coupled together by a side surface 2351 that is substantially perpendicular to the top and bottom surfaces. The transmitting module 2408 comprises a rectangular shaped body that includes a controller and one or more UV light sources. Batteries 122 may be coupled to a side of the transmitting module and the transmitting module may be sized to fit within a space defined by the walls of the outer shell 2406. Interior surfaces of the outer shell may include slots 2505 shaped to mate with corresponding components on the outer surface of transmitting module to releasably lock the transmitting module within the outer shell 2406.
In some examples, one or more light lenses may be included within an interior of the transmitting module adjacent to each port inlet to direct UV light from the UV light source(s) towards any access site coupled to the port inlet. Additionally, switches may be included within the interior of the transmitting module adjacent to each port inlet to automatically actuate the device in response to attachment of an access site to a port inlet. For example, an interference component may be included in the transmitting module adjacent to internal threads of a port inlet such that when an access port is twisted into the port inlet, the access port engages the interference component to actuate UV disinfection of the access site.
Transmitting module 2408 also includes doors 181 at each of the front and back faces. Each door at each face may be rotatably coupled to an edge of the face, e.g., via a spring-loaded hinge that biases the door into a closed position over the port inlet in the face.
As illustrated in
In some embodiments, the above described methods and processes may be tied to a computing system including one or more computers. In particular, the methods and processes described herein may be implemented as a computer application, computer service, computer API, computer library, and/or other computer program product. For example, method 1000 described above may be implemented via controller 120 included in device 100. Controller 120 may be any suitable computing device or microprocessor. As another example, device 100 may be regarded as a computing device configured to maintain disinfection of access ports of medical devices as described above.
Computing device 2700 includes a logic subsystem 2702 and a data-holding subsystem 2704. Computing device 2700 may optionally include a notification subsystem 2706 and a communication subsystem 2708, and/or other components not shown in
Logic subsystem 2702 may include one or more physical devices configured to execute one or more machine-readable instructions. For example, the logic subsystem may be configured to execute one or more instructions that are part of one or more applications, services, programs, routines, libraries, objects, components, data structures, or other logical constructs. Such instructions may be implemented to perform a task, implement a data type, transform the state of one or more devices, or otherwise arrive at a desired result.
The logic subsystem may include one or more processors that are configured to execute software instructions. Additionally or alternatively, the logic subsystem may include one or more hardware or firmware logic machines configured to execute hardware or firmware instructions. Processors of the logic subsystem may be single core or multicore, and the programs executed thereon may be configured for parallel or distributed processing. The logic subsystem may optionally include individual components that are distributed throughout two or more devices, which may be remotely located and/or configured for coordinated processing. One or more aspects of the logic subsystem may be virtualized and executed by remotely accessible networked computing devices configured in a cloud computing configuration.
Data-holding subsystem 2704 may include one or more physical, non-transitory, devices configured to hold data and/or instructions executable by the logic subsystem to implement the herein described methods and processes. When such methods and processes are implemented, the state of data-holding subsystem 2704 may be transformed (e.g., to hold different data).
Data-holding subsystem 2704 may include removable media and/or built-in devices. Data-holding subsystem 2704 may include optical memory devices (e.g., CD, DVD, HD-DVD, Blu-Ray Disc, etc.), semiconductor memory devices (e.g., RAM, EPROM, EEPROM, etc.), and/or magnetic memory devices (e.g., hard disk drive, floppy disk drive, tape drive, MRAM, etc.), among others. Data-holding subsystem 2704 may include devices with one or more of the following characteristics: volatile, nonvolatile, dynamic, static, read/write, read-only, random access, sequential access, location addressable, file addressable, and content addressable. In some embodiments, logic subsystem 2702 and data-holding subsystem 2704 may be integrated into one or more common devices, such as an application specific integrated circuit or a system on a chip.
When included, notification subsystem 2706 may be used to present visual and/or audio and/or haptic representations of data held by data-holding subsystem 2704. As the herein described methods and processes change the data held by the data-holding subsystem, and thus transform the state of the data-holding subsystem, the state of notification subsystem 2706 may likewise be transformed to visually and/or sonically and/or haptically represent changes in the underlying data. Notification subsystem 2706 may include one or more display devices utilizing virtually any type of technology. Such display devices may be combined with logic subsystem 2702 and/or data-holding subsystem 2704 in a shared enclosure, or such display devices may be peripheral display devices. Notification subsystem 2706 may include one or more audio devices, e.g., one or more speakers, and/or one or more haptic devices utilizing virtually any type of technology.
When included, communication subsystem 2708 may be configured to communicatively couple computing device 2700 with one or more other computing devices. Communication subsystem 2708 may include wired and/or wireless communication devices compatible with one or more different communication protocols. As nonlimiting examples, the communication subsystem may be configured for communication via a wireless telephone network, a wireless local area network, a wired local area network, a wireless wide area network, a wired wide area network, etc. In some embodiments, the communication subsystem may allow computing device 2700 to send and/or receive messages to and/or from other devices via a network such as the Internet.
Attachment devices may be included in the system to attach one or more of the above illustrated devices to a patient. For example, an adhesive gel may be provided on an external surface of one of the above housings (e.g., at 2351) for temporary attachment to a patient's skin. The gel may be a hydrogel, and in one example may be a colloid hydrogel patch. Additionally or alternatively, a clip may be provided to engage to a patient's clavicle and or clothing. Further, a shoulder bag may also be coupled with the device so that it may be worn by a patient. Still another example may include a fabric bandage material coupled to the device for coupling to a patient's skin.
It is to be understood that the configurations and/or approaches described herein are exemplary in nature, and that these specific embodiments or examples are not to be considered in a limiting sense, because numerous variations are possible. The specific routines or methods described herein may represent one or more of any number of processing strategies. As such, various acts illustrated may be performed in the sequence illustrated, in other sequences, in parallel, or in some cases omitted. Likewise, the order of the above-described processes may be changed.
The subject matter of the present disclosure includes all novel and nonobvious combinations and subcombinations of the various processes, systems and configurations, and other features, functions, acts, and/or properties disclosed herein, as well as any and all equivalents thereof.
The present application claims priority to U.S. Provisional Patent Application No. 61/916,876, filed Dec. 17, 2013, entitled “ULTRAVIOLET DISINFECTION OF MEDICAL DEVICE ACCESS SITES,” the entire disclosure of which is hereby incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2014/070980 | 12/17/2014 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
61916876 | Dec 2013 | US |